In vitro effects of conditioned medium from bioreactor cultured human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on skin-derived cell lines.
Anti-aging
Anti-apoptosis
Growth factors
Human stem cell-conditioned medium
Hyaluronic acid
Melanogenesis
Journal
Regenerative therapy
ISSN: 2352-3204
Titre abrégé: Regen Ther
Pays: Netherlands
ID NLM: 101709085
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
21
05
2021
revised:
30
07
2021
accepted:
09
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
When stem cells are grafted into tissues, they differentiate and form specialized cells. However, the proficiency of stem cells to endure and assimilate the host cell is dependent on various growth factors and cytokines. According to various studies, these factors are available in the spent media of harvested stem cells, which can be used for treatment in regenerative medicine and cosmetic products. There are differences in cytokine secretion depending on the culture environment, which are clarified in this paper. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) were cultured either in a bioreactor or in a flask. The conditioned medium from the hUC-MSC cultures in the flask and in the bioreactor was designated as "FM" and "BM", respectively. We assessed the effects of FM and BM on UVB-induced oxidative stress, anti-aging, and melanogenic properties. The amount of growth factors, cell viability, hyaluronic acid (HA), pro-collagen, and pro-melanin were quantitatively evaluated in the FM and BM treated groups. The induction of HA and collagen synthesis was measured in CCD-986SK cells. For melanogenesis, the effects of FM and BM on melanin content and tyrosinase activity were measured in SK-MEL-31 cells. In the present study, the secretion of growth factors, HA, and pro-collagen was significantly higher in the BM treatment, compared to that in the FM treatment. BM protected CCD-986SK cells against death from UVB induced oxidative stress. BM increased the promoter activity of the anti-oxidant genes SOD1, CAT, and GP; and downregulated the accelerating collagen decomposition gene, MMP-1, induced by UVB irradiation. In α-melanocyte-stimulating hormone (α-MSH) stimulated SK-MEL-31 cells, BM reduced melanin production and decreased the levels of MITF, tyrosinase, TRP-1, and TRP-2. These results suggest that BM could be used as a skin protection agent, because of its anti-apoptotic, anti-aging, and anti-melanogenic properties. This could be attributed to the differences in culturing methods; it is difficult to maintain the temperature and sterility in FM culture, when compared to that in the automated culturing conditions of the BM system. Collectively, our results indicate that using BM-conditioned hUC-MSC medium is very efficient process for producing raw materials for developing functional cosmetics.
Identifiants
pubmed: 34504909
doi: 10.1016/j.reth.2021.08.003
pii: S2352-3204(21)00062-6
pmc: PMC8390454
doi:
Types de publication
Journal Article
Langues
eng
Pagination
281-291Informations de copyright
© 2021 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Déclaration de conflit d'intérêts
None.
Références
Spat Demogr. 2020 Jul;8(2):155-173
pubmed: 34222615
Redox Biol. 2015 Dec;6:183-197
pubmed: 26233704
Am J Pathol. 2020 Jul;190(7):1356-1369
pubmed: 32246919
Pigment Cell Res. 2000 Apr;13(2):60-9
pubmed: 10841026
Appl Biochem Biotechnol. 2017 Mar;181(3):1228-1239
pubmed: 27744524
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2015-2025
pubmed: 28499917
Clin Cosmet Investig Dermatol. 2016 Nov 09;9:411-419
pubmed: 27877059
Arch Dermatol Res. 2009 Aug;301(7):487-95
pubmed: 19373483
J Pathol. 2004 Jul;203(3):831-8
pubmed: 15221943
Biomed Res Int. 2014;2014:965849
pubmed: 25530971
Climacteric. 2013 Oct;16(5):514-21
pubmed: 23659624
Dermatoendocrinol. 2012 Jul 1;4(3):253-8
pubmed: 23467280
Cytotherapy. 2014 Aug;16(8):1048-58
pubmed: 24726657
Antioxid Redox Signal. 2011 Sep 15;15(6):1583-606
pubmed: 21473702
Br J Dermatol. 2013 Mar;168(3):533-8
pubmed: 23363376
Cell Transplant. 2015;24(3):339-47
pubmed: 25622293
Wound Repair Regen. 2012 Mar-Apr;20(2):178-84
pubmed: 22304391
Skin Pharmacol Physiol. 2019;32(5):275-282
pubmed: 31352445
J Vet Sci. 2012 Sep;13(3):299-310
pubmed: 23000587
Stem Cell Res. 2016 May;16(3):696-711
pubmed: 27107345
Stem Cells Int. 2019 Dec 17;2019:9208173
pubmed: 31933651
Stem Cell Res Ther. 2019 Mar 29;10(1):111
pubmed: 30922387
J Cell Biol. 1998 Jun 15;141(6):1423-32
pubmed: 9628898
Int J Stem Cells. 2009 May;2(1):59-68
pubmed: 24855521
Pigment Cell Res. 2005 Feb;18(1):25-33
pubmed: 15649149
Int J Mol Sci. 2020 Jul 28;21(15):
pubmed: 32731615
Regen Med. 2010 Jan;5(1):121-43
pubmed: 20017699
J Surg Res. 2015 Mar;194(1):8-17
pubmed: 25475020
Dermatol Ther (Heidelb). 2018 Jun;8(2):229-244
pubmed: 29500741
Mol Med Rep. 2018 Jan;17(1):861-869
pubmed: 29115623
World Allergy Organ J. 2012 Jan;5(1):9-19
pubmed: 23268465
J Invest Dermatol. 2002 Dec;119(6):1330-40
pubmed: 12485436